Biogen's CEO steps down, Theranos brings on a team to right its wrongs and FDA's Hall leaves for PatientsLikeMe. Plus more hirings, firings and…

As expected, an FDA panel voted in favor of giving Dexcom’s G5 continuous glucose monitor a nonadjunctive indication that would allow it to be used in place of…

Former Acclarent CEO Bill Facteau has dealt with his fair share of legal drama after the Department of Justice (DOJ) accused him of improperly marketing one of…

ElectroCore is doing some shuffling. Frank Amato has been bumped up to the CEO position after having served as chief operating officer for the Merck-backed med…

Fresh off a positive FDA panel earlier this month for what could be its first approved biosimilar for Humira, Amgen--and partner Allergan--have reported…

Beleaguered Theranos has hired a pair of industry executives in an apparent effort to right a ship that has been foundering in light of questions regarding the…

Brexit rejig leaves the U.K. without a life science minister, Shire takes a stake in Chronos, Poxel postpones its IPO and more.

Galderma Pharma has picked up the rights to a midphase atopic dermatitis and pruritus drug from Roche’s Chugai Pharmaceutical.